Skip to content

MiMedx Group MDXG Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

Solventum logo
SolventumSOLV
Globus Medical logo
Globus MedicalGMED
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's interest income (expense), nonoperating?
MiMedx Group (MDXG) reported interest income (expense), nonoperating of $886K in Q1 2026.
How has MiMedx Group's interest income (expense), nonoperating changed year-over-year?
MiMedx Group's interest income (expense), nonoperating increased by 75.1% year-over-year, from $506K to $886K.
What is the long-term trend for MiMedx Group's interest income (expense), nonoperating?
Over 2 years (2022 to 2025), MiMedx Group's interest income (expense), nonoperating has grown at a -23.5% compound annual growth rate (CAGR), from -$5.02M to $2.93M.